Logo Stage

Juno Therapeutics GmbH

Rudolf-Wissell-Str. 28
D-37079 Göttingen

Phone: +49 (0) 551 506 72-111
Fax: +49 (0) 551 506 72-182

http://www.junotherapeutics.com/

Company presentation

Juno Therapeutics GmbH is a biotech company active since 2005. Based on its proprietary Streptamer® technology, Juno is aiming to become an important player in cell therapy. The unique Streptamer® platform enables the rapid development and production of safe and efficient cell therapeutics.

Juno Therapeutics GmbH has initiated with experts in the field a clinical study (phase I/II) to treat CMV infection after stem cell transplantation of patients suffering from hematologic malignancies. First clinical data from treated patients are looking extremely promising.

Juno Therapeutics GmbH invites experts in cell therapy to use the Streptamer® technology for other clinical applications. Various cooperations focusing on different indications have been established resulting in a rich product pipeline.

Lead investigator

Lothar Germeroth

Dr. Lothar Germeroth

Phone: +49 (0)551 50672 111
Fax: +49 (0)551 50672 181

contact

Dr. Herbert Stadler

contact

Claudia Tschulik

Lab technician

contact

Christian Stemberger

Dr. Christian Stemberger

Scientist

contact

Stefan Dreher

Dr. Stefan Dreher

Scientist

contact

Kirsten Weiss

Kirsten Weiss

Scientist / GMP manufacturing

Kristian Stanar

Christian Stanar

Lab technician

Christine Piossek

Dr. Christine Piossek

Scientist

Press release

Press release on the occasion of the signed Grant Agreement for T-Control: here.